Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

Share Price is delayed by 15 minutes
Get Live Data
373.00    4.50 (1.22%)
Bid:
368.00
Ask:
373.00
Spread: 5.00 (1.359%)
Market Cap: £1.91b
CLDN Live PriceLast checked at - London Stock Exchange

Intraday Caledonia Share Chart

2023 AGM results update statement

19 Jan 2024 16:30

RNS Number : 3461A
Caledonia Investments PLC
19 January 2024

Caledonia Investments plc

2023 annual general meeting ("AGM") results update statement

In accordance with Provision 4 of the UK Corporate Governance Code, Caledonia Investments plc (the "Company") provides an update on the feedback received and any actions the Company intends to take following the outcome of voting in respect of resolution 19 at the 2023 AGM.

Resolution 19 was the waiver of the mandatory offer provisions set out in Rule 9 of The City Code on Takeovers and Mergers in relation to the Cayzer family concert party, given the obligation that could arise on the concert party to make a general offer for the entire issued share capital of the Company as a result of purchases by the Company of ordinary shares pursuant to the authority received from shareholders to make market purchases.

Resolution 19 passed with a majority of votes cast by independent shareholders in favour. However, more than 20% of participating independent shareholders voted against. This included one large shareholder who, having previously supported the resolution, recently adopted a policy of voting in line with the voting recommendations of a proxy voting advisor which is generally not supportive of such Rule 9 waiver resolutions given their potential to lead to creeping control. In response to the feedback received from this shareholder, who continues to be supportive of management, the Company continues to engage with this proxy voting advisor.

The Company is grateful to all those that have taken the time to engage on this issue. We recognise the concern raised by the proxy voting advisor. However, the directors believe that the Company's ability to exercise the authority to make market purchases of its own shares warranted approval of the Rule 9 waiver resolution.

19 January 2024

For further information please contact:

Company contacts

Caledonia Investments plc

+44 20 7802 8080

David Stewart

Chairman

Media contacts

Teneo

+44 20 7353 4200

Tom Murray

Robert Yates

caledonia@teneo.com

END

Notes for editors:

Caledonia Investments plc

Caledonia is a self-managed investment trust company. Our aim is to grow net assets and dividends paid to shareholders, whilst managing risk to avoid the permanent loss of capital. We achieve this by investing in proven, well-managed businesses that combine long term growth characteristics with an ability to deliver increasing levels of income. We hold investments in both listed and private markets, covering a range of sectors and, particularly through the listed and fund investments, have a global reach.

For additional information on Caledonia, please visit www.caledonia.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
AGMSFSFLUELSEIF
Date   Source Headline
31st May 20224:50 pmRNSDirector/PDMR Shareholding
26th May 20227:00 amRNSFinal Results
6th May 20229:02 amRNSNet Asset Value(s)
7th Apr 20227:00 amRNSUnaudited net asset value and portfolio update
4th Apr 202210:10 amRNSDirectorate Change
25th Mar 20224:47 pmRNSDirector/PDMR Shareholding
21st Mar 20223:56 pmRNSDirector/PDMR Shareholding
16th Mar 20222:05 pmRNSDirector/PDMR Shareholding
7th Mar 20227:00 amRNSDirectorate Change
7th Mar 20227:00 amRNSNet Asset Value(s)
28th Feb 20224:59 pmRNSTotal Voting Rights
4th Feb 20224:56 pmRNSTransaction in Own Shares
4th Feb 20229:52 amRNSNet Asset Value(s)
31st Jan 20225:23 pmRNSTotal Voting Rights
28th Jan 20225:25 pmRNSTransaction in Own Shares
7th Jan 202211:40 amRNSUnaudited net asset value and portfolio update
4th Jan 20227:00 amRNSTotal Voting Rights
21st Dec 20214:44 pmRNSDisposal
20th Dec 202110:00 amRNSDirector Declaration
17th Dec 20215:32 pmRNSTransaction in Own Shares
10th Dec 20215:16 pmRNSTransaction in Own Shares
7th Dec 20219:59 amRNSNet Asset Value(s)
30th Nov 20215:30 pmRNSTotal Voting Rights
26th Nov 20214:49 pmRNSTransaction in Own Shares
23rd Nov 20217:00 amRNSBoard Changes
23rd Nov 20217:00 amRNSHalf-year Report
17th Nov 20217:00 amRNSDisposal
4th Nov 202111:22 amRNSNet Asset Value(s)
1st Nov 20219:35 amRNSTotal Voting Rights
29th Oct 20214:49 pmRNSTransaction in Own Shares
15th Oct 20214:57 pmRNSTransaction in Own Shares
8th Oct 20215:16 pmRNSTransaction in Own Shares
7th Oct 202110:48 amRNSNet Asset Value(s)
30th Sep 20215:02 pmRNSTotal Voting Rights
30th Sep 20214:59 pmRNSTransaction in Own Shares
30th Sep 20211:52 pmRNSTransaction in Own Shares
24th Sep 20214:57 pmRNSTransaction in Own Shares
17th Sep 20215:05 pmRNSTransaction in Own Shares
10th Sep 20215:05 pmRNSTransaction in Own Shares
3rd Sep 20215:04 pmRNSTransaction in Own Shares
3rd Sep 202112:12 pmRNSDirector/PDMR Shareholding
31st Aug 20216:00 pmRNSTotal Voting Rights
27th Aug 20215:10 pmRNSTransaction in Own Shares
20th Aug 20214:56 pmRNSTransaction in Own Shares
20th Aug 202110:41 amRNSHolding(s) in Company
13th Aug 20215:13 pmRNSTransaction in Own Shares
9th Aug 202112:12 pmRNSHolding(s) in Company
6th Aug 20215:10 pmRNSTransaction in Own Shares
5th Aug 20219:19 amRNSNet Asset Value(s)
2nd Aug 20217:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.